Paraoxonase is another enzyme used as a biomarker of oxidative stress; anti-inflammatory activity has been reported in models of Alzheimer’s disease and hyperlipidemia, where reduced PON activity has been observed [71]. The gene discussed is PON1; the disease is early-onset autosomal dominant Alzheimer disease.